Svoz Indications/Uses

Svoz: Moxifloxacin is used for the treatment of infections caused by susceptible strains of the designated microorganisms in the following conditions: Acute sinusitis; Respiratory tract infections: Acute exacerbations of chronic bronchitis, Community acquired pneumonia; Uncomplicated skin and skin structure infections; Complicated skin and skin structure infections; Complicated intra-abdominal infections; Uncomplicated pelvic inflammatory disease.
Svoz Infusion: Moxifloxacin is indicated for the treatment of the following bacterial infections caused by susceptible strains in the following conditions: Community acquired pneumonia (CAP) including CAP caused by multidrug-resistant strains*; Complicated skin and skin structure infections (including diabetic foot infections); Complicated intra-abdominal infections including polymicrobial infections such as abscesses.
*Multidrug-resistant Streptococcus pneumoniae (MDRSP) includes isolates known as Penicillin-resistant Streptococcus pneumoniae (PRSP), and strains resistant to two or more of the following antibiotics: penicillin (MIC ≥2 µg/mL), 2^nd generation cephalosporins (e.g., cefuroxime), macrolides, tetracyclines and trimethoprim/sulfamethoxazole.
Consideration should be given to official guidance on the appropriate use of antibacterial agents.